Arcus Biosciences annual net debt
2020
2021
2022
2023
2024
2025
Arcus Biosciences Net Debt Growth & History (RCUS)
Arcus Biosciences's net debt was −$24.0M for fiscal 2025.
View full Arcus Biosciences company overviewArcus Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$24.0M | −$33.0M | — |
| 2024 | 2024-12-31 | $9.0M | $15.0M | — |
| 2023 | 2023-12-31 | −$6.0M | $74.0M | — |
| 2022 | 2022-12-31 | −$80.0M | −$45.6M | — |
| 2021 | 2021-12-31 | −$34.4M | $120.9M | — |
| 2020 | 2020-12-31 | −$155.3M | — | — |
Arcus Biosciences quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$36.0M | $103.0M | — |
| Q1 2026 | 2026-03-31 | −$88.0M | $44.0M | — |
| Q4 2025 | 2025-12-31 | −$24.0M | −$33.0M | — |
| Q3 2025 | 2025-09-30 | −$127.0M | $16.0M | — |
| Q2 2025 | 2025-06-30 | −$139.0M | $6.0M | — |
| Q1 2025 | 2025-03-31 | −$132.0M | $42.0M | — |
| Q4 2024 | 2024-12-31 | $9.0M | $15.0M | — |
| Q3 2024 | 2024-09-30 | −$143.0M | $32.0M | — |
| Q2 2024 | 2024-06-30 | −$145.0M | — | — |
| Q1 2024 | 2024-03-31 | −$174.0M | — | — |
| Q4 2023 | 2023-12-31 | −$6.0M | $74.0M | — |
| Q3 2023 | 2023-09-30 | −$175.0M | −$76.2M | — |
| Q4 2022 | 2022-12-31 | −$80.0M | −$45.6M | — |
| Q3 2022 | 2022-09-30 | −$98.8M | $28.9M | — |
| Q2 2022 | 2022-06-30 | −$151.7M | $116.6M | — |
| Q1 2022 | 2022-03-31 | −$434.2M | −$58.6M | — |
| Q4 2021 | 2021-12-31 | −$34.4M | $120.9M | — |
| Q3 2021 | 2021-09-30 | −$127.7M | — | — |
| Q2 2021 | 2021-06-30 | −$268.3M | — | — |
| Q1 2021 | 2021-03-31 | −$375.6M | — | — |
| Q4 2020 | 2020-12-31 | −$155.3M | — | — |
Arcus Biosciences net debt trends
Over the last five fiscal years, Arcus Biosciences's net debt increased from −$155.3M to −$24.0M, a change of $131.3M. The latest reported quarter, Q2 2026, shows −$36.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcus Biosciences source filings ↗Community posts
Arcus sets $17.50 share price for $250 million equity financing
Arcus Biosciences ($RCUS) priced an underwritten public offering of 14,285,715 new common shares at $17.50 apiece, targeting approximately $250 million in gross proceeds. The company is selling all of the shares, so the financing would add ...
Arcus reports additional kidney-cancer data supporting casdatifan development
Arcus Biosciences ($RCUS) released additional results from the ARC-20 program evaluating casdatifan in kidney cancer. Across pooled monotherapy cohorts involving 121 heavily pretreated patients, median overall survival was 35 months, median ...
